Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...

Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...

Real-world results may differ from those seen in clinical trials for CAR T-cell therapy and bispecific antibodies for the ...

B cells are a subtype of lymphocyte. They form part of the adaptive immune response and mediate humoral immunity. B cells can produce high-affinity antibodies and generate immunological memory ...

T-Mobile is the third-largest wireless carrier in the United States, with its popularity largely down to its network coverage and the wide range of tempting offers available. They span from T ...

Researchers from the Josep Carreras Leukaemia Research Institute have found that the efficacy of varni-cel, a CAR-T infusion ...

Andrew is CNET's go-to guy for product coverage and lead photographer for Europe. When not testing the latest phones, he can normally be found with his camera in hand, behind his drums or eating ...

Kia was launching its first ute ever—the Kia Tasman—but there were a couple of issues: Kia couldn’t show the ute as it was still in development. Kia’s never made an off-road vehicle before ...

Ivory Coast had long been a haven for L.G.B.T.Q. people, even as they faced discrimination or persecution elsewhere in West Africa. But over the past two months, dozens of assaults, beatings and ...

AT&T has played second fiddle to Verizon for a while now, but even T-Mobile is frequently starting to outshine it. Should you make the swap to T-Mobile, or AT&T the better fit? Let’s place AT&T ...

Leo Burnett has won the creative account for ANZ following a competitive pitch, sources close to the pitch have told B&T. The partnership represents a pivotal moment in ANZ’s ongoing evolution ...